Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions.


Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
07 11 2019
Historique:
received: 16 05 2019
revised: 03 07 2019
accepted: 25 07 2019
pubmed: 10 9 2019
medline: 26 2 2020
entrez: 10 9 2019
Statut: ppublish

Résumé

Transcriptional responses to external stimuli remain poorly understood. Using global nuclear run-on followed by sequencing (GRO-seq) and precision nuclear run-on sequencing (PRO-seq), we show that CDK8 kinase activity promotes RNA polymerase II pause release in response to interferon-γ (IFN-γ), a universal cytokine involved in immunity and tumor surveillance. The Mediator kinase module contains CDK8 or CDK19, which are presumed to be functionally redundant. We implemented cortistatin A, chemical genetics, transcriptomics, and other methods to decouple their function while assessing enzymatic versus structural roles. Unexpectedly, CDK8 and CDK19 regulated different gene sets via distinct mechanisms. CDK8-dependent regulation required its kinase activity, whereas CDK19 governed IFN-γ responses through its scaffolding function (i.e., it was kinase independent). Accordingly, CDK8, not CDK19, phosphorylates the STAT1 transcription factor (TF) during IFN-γ stimulation, and CDK8 kinase inhibition blocked activation of JAK-STAT pathway TFs. Cytokines such as IFN-γ rapidly mobilize TFs to "reprogram" cellular transcription; our results implicate CDK8 and CDK19 as essential for this transcriptional reprogramming.

Identifiants

pubmed: 31495563
pii: S1097-2765(19)30589-1
doi: 10.1016/j.molcel.2019.07.034
pmc: PMC6842433
mid: NIHMS1536540
pii:
doi:

Substances chimiques

IFNG protein, human 0
IFNG protein, mouse 0
STAT1 Transcription Factor 0
STAT1 protein, human 0
Stat1 protein, mouse 0
Interferon-gamma 82115-62-6
CDK19 protein, human EC 2.7.11.22
CDK19 protein, mouse EC 2.7.11.22
CDK8 protein, human EC 2.7.11.22
Cdk8 protein, mouse EC 2.7.11.22
Cyclin-Dependent Kinase 8 EC 2.7.11.22
Cyclin-Dependent Kinases EC 2.7.11.22
RNA Polymerase II EC 2.7.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

485-499.e8

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM117370
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008759
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150305
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA117907
Pays : United States
Organisme : Austrian Science Fund FWF
ID : P 31848
Pays : Austria
Organisme : NIGMS NIH HHS
ID : T32 GM142607
Pays : United States
Organisme : NIH HHS
ID : S10 OD012300
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120109
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Methods. 2015 Jan 15;72:29-40
pubmed: 25448294
Nat Protoc. 2016 Aug;11(8):1455-76
pubmed: 27442863
Cell Rep. 2014 May 8;7(3):654-60
pubmed: 24746821
Nat Genet. 2006 May;38(5):500-1
pubmed: 16642009
Science. 2008 Dec 19;322(5909):1845-8
pubmed: 19056941
Nature. 2015 Aug 13;524(7564):230-3
pubmed: 26168398
Nature. 2015 Oct 8;526(7572):273-276
pubmed: 26416749
Cell Rep. 2017 Nov 7;21(6):1495-1506
pubmed: 29117556
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13956-61
pubmed: 10570180
J Virol. 1996 Jan;70(1):647-50
pubmed: 8523587
Genome Res. 2018 Feb 15;:
pubmed: 29449408
Nat Cell Biol. 2014 Nov;16(11):1080-91
pubmed: 25344755
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Cell. 1995 Jul 28;82(2):241-50
pubmed: 7543024
Genome Biol. 2016 Jul 05;17(1):148
pubmed: 27380939
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
J Cell Biol. 1963 May;17:299-313
pubmed: 13985244
Mol Cell Biol. 2015 Feb;35(4):716-27
pubmed: 25512607
Nature. 2011 Aug 24;477(7364):340-3
pubmed: 21866103
Nat Chem Biol. 2015 Dec;11(12):973-980
pubmed: 26502155
Science. 2015 Feb 27;347(6225):1010-4
pubmed: 25678556
Nucleic Acids Res. 2007;35(12):e87
pubmed: 17576687
Genome Biol. 2014;15(12):550
pubmed: 25516281
ACS Med Chem Lett. 2016 Jan 06;7(3):223-8
pubmed: 26985305
Mol Cell Biol. 2009 Feb;29(3):650-61
pubmed: 19047373
Mol Cell Biol. 2017 Jun 15;37(13):
pubmed: 28416637
Nucleic Acids Res. 2013 May 1;41(10):e108
pubmed: 23558742
J Comput Biol. 2017 Nov;24(11):1138-1143
pubmed: 28715235
EBioMedicine. 2017 Dec;26:112-125
pubmed: 29239838
Nat Chem Biol. 2017 Oct;13(10):1102-1108
pubmed: 28805801
J Interferon Cytokine Res. 2016 Jul;36(7):462-9
pubmed: 27379868
Nucleic Acids Res. 2013 Jan;41(Database issue):D195-202
pubmed: 23175603
Mol Cell. 2007 Jul 6;27(1):121-33
pubmed: 17612495
Immunity. 2013 Feb 21;38(2):250-62
pubmed: 23352233
Elife. 2014 May 27;3:e02200
pubmed: 24867637
Physiol Genomics. 2007 Sep 19;31(1):32-41
pubmed: 17456738
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Science. 2013 Feb 22;339(6122):950-3
pubmed: 23430654
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7673-8
pubmed: 8755534
Cell Rep. 2016 Apr 12;15(2):436-50
pubmed: 27050516
RNA. 2008 Sep;14(9):1959-72
pubmed: 18658122
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10208-10213
pubmed: 28855340
Nat Rev Mol Cell Biol. 2015 Mar;16(3):155-66
pubmed: 25693131
Cell. 2013 Jun 6;153(6):1327-39
pubmed: 23746844
Nat Rev Immunol. 2018 Sep;18(9):545-558
pubmed: 29921905
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
J Interferon Cytokine Res. 1997 Mar;17(3):121-34
pubmed: 9085936
Nucleic Acids Res. 2015 Mar 31;43(6):e40
pubmed: 25564527
Methods Mol Biol. 2016;1418:335-51
pubmed: 27008022
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8944-9
pubmed: 18574148

Auteurs

Iris Steinparzer (I)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Vitaly Sedlyarov (V)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.

Jonathan D Rubin (JD)

Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA.

Kevin Eislmayr (K)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Matthew D Galbraith (MD)

Linda Crnic Institute for Down Syndrome, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Cecilia B Levandowski (CB)

Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA.

Terezia Vcelkova (T)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Lucy Sneezum (L)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Florian Wascher (F)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Fabian Amman (F)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria; Department of Theoretical Chemistry of the University of Vienna, 1090 Vienna, Austria.

Renata Kleinova (R)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Heather Bender (H)

Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Zdenek Andrysik (Z)

Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Joaquin M Espinosa (JM)

Linda Crnic Institute for Down Syndrome, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Pharmacology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Giulio Superti-Furga (G)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria; Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.

Robin D Dowell (RD)

BioFrontiers Institute, University of Colorado, Boulder, CO 80309, USA; Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA.

Dylan J Taatjes (DJ)

Department of Biochemistry, University of Colorado, Boulder, CO 80303, USA. Electronic address: taatjes@colorado.edu.

Pavel Kovarik (P)

Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria. Electronic address: pavel.kovarik@univie.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH